Alex M. Azar II - 12 Sep 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Alex M. Azar II
Issuer symbol
GH
Transactions as of
12 Sep 2025
Net transactions value
$0
Form type
4
Filing time
26 Sep 2025, 17:04:57 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Azar Alex M II Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Alex M. Azar II 26 Sep 2025 0001402256

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Stock Option (Right to Buy) Award $0 +10,532 $0.000000 10,532 12 Sep 2025 Common Stock 10,532 $54.90 Direct F1
transaction GH Restricted Stock Units Award $0 +6,604 $0.000000 6,604 12 Sep 2025 Common Stock 6,604 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of September 12, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
F2 The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of September 12, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
F3 Not applicable for Restricted Stock Units.